0.00Open99.96Pre Close0 Volume0 Open Interest680.00Strike Price0.00Turnover0.00%IV1.94%PremiumJan 3, 2025Expiry Date85.10Intrinsic Value100Multiplier-2DDays to Expiry14.86Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma7.65Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Eli Lilly and Co Stock Discussion
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
No comment yet